-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the American College of Rheumatology (ACR) published a summary
of new guidelines for vaccinating patients with rheumatology and musculoskeletal disorders (RMD).
The new guidelines expand the indications for certain vaccines in patients with wet and musculoskeletal disorders (RMD), provide guidance on drug stewardship at the time of vaccination, and discuss safe approaches
to live attenuated vaccines in patients taking immunosuppressive drugs.
Indications expanded
*A "strong" recommendation means that the benefits of treatment outweigh the risks and that almost or all panelists agree with the recommendation; A "conditional" recommendation means that the risks and benefits are comparable or uncertain, and only a majority of expert members agree with the recommendation
.
Drug management
In addition, one recommendation that differs from current criteria is that newborns of mothers treated with tumor necrosis factor (TNF) inhibitors in the second or third trimester of pregnancy should receive rotavirus vaccine within 6 months of life, and newborns of mothers receiving rituximab should receive rotavirus vaccine after 6 months (pictured).
